Esmya is a medicine for treating moderate to severe symptoms of uterine fibroids. Uterine fibroids are non-cancerous (benign) tumours of the womb (uterus). Esmya is for use only in women who have not yet reached the menopause and in whom fibroid embolisation (a non-surgical procedure to block off the arteries that feed the fibroids) or surgery are not suitable or have not worked. The medicine contains the active substance ulipristal acetate.
Therapeutic Indication
### Therapeutic indication Ulipristal acetate is indicated for pre-operative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age. Ulipristal acetate is indicated for intermittent treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.
Therapeutic Area (MeSH)
ATC Code
G03XB02
ATC Item
ulipristal
Pharmacotherapeutic Group
Sex hormones and modulators of the genital system
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| ulipristal acetate | N/A | Ulipristal |
EMA Name
Esmya
Medicine Name
Esmya
Aliases
N/ANo risk management plan link.
